Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.18 USD -4.21% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supernus Pharmaceuticals Inc
Common Stock Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Common Stock
$55k
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Common Stock
$3.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Bristol-Myers Squibb Co
NYSE:BMY
Common Stock
$292m
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
3%
Pfizer Inc
NYSE:PFE
Common Stock
$480m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Common Stock
$1.8B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Common Stock
$593.9m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-2%

See Also

What is Supernus Pharmaceuticals Inc's Common Stock?
Common Stock
55k USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Common Stock amounts to 55k USD.

What is Supernus Pharmaceuticals Inc's Common Stock growth rate?
Common Stock CAGR 5Y
-11%

Over the last year, the Common Stock growth was -45%. The average annual Common Stock growth rates for Supernus Pharmaceuticals Inc have been -18% over the past three years , -11% over the past five years .

Back to Top